arsenic trioxide has been researched along with leupeptins in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaudhary, PM; Matta, H; Sun, Q | 1 |
Chen, SC; Chou, Y; Tian, TY; Tsai, CH; Ueng, KC; Yeh, HI | 1 |
Berthoux, L; Bérubé, J; Nepveu-Traversy, ME | 1 |
Berthoux, L; Létourneau-Hogan, A; Malbec, M; Nepveu-Traversy, ME; Pham, QT; Plourde, MB | 1 |
Battastini, AM; Braganhol, E; Dalmolin, RJ; de Souza, LH; Gelain, DP; Moreira, JC; Pasquali, MA; Schröder, R; Zanotto-Filho, A | 1 |
Chen, X; Jung, YS; Yan, W; Zhang, J; Zhang, Y | 1 |
Alvarez, EM; Blanco, GA; Cavaliere, V; Costantino, SN; Kornblihtt, L; Lombardo, T | 1 |
Ho, JC; Lam, SK; Leung, LL; Li, YY; Zheng, CY | 1 |
8 other study(ies) available for arsenic trioxide and leupeptins
Article | Year |
---|---|
The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation.
Topics: Acetylcysteine; Acute Disease; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Cell Transformation, Viral; Enzyme Activation; Gene Expression Regulation, Viral; Granulocyte-Macrophage Colony-Stimulating Factor; Herpesvirus 8, Human; Humans; I-kappa B Proteins; Leukemia, Myeloid; Leupeptins; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; NF-kappa B; Oxides; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Recombinant Proteins; Rhadinovirus; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Proteins | 2003 |
Endothelial gap junctions are down-regulated by arsenic trioxide.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line; Connexin 43; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Gap Junctions; Humans; Immunohistochemistry; Leupeptins; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxides; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; von Willebrand Factor | 2007 |
TRIM5alpha and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors.
Topics: Animals; Aotidae; Arsenic Trioxide; Arsenicals; Cell Line; Cyclosporine; Enzyme Inhibitors; Leupeptins; Macaca mulatta; Mice; Oxides; Protein Multimerization; Proteins; Ubiquitin-Protein Ligases | 2009 |
Murine double minute 2 as a modulator of retroviral restrictions mediated by TRIM5alpha.
Topics: Animals; Antiviral Restriction Factors; Arsenic Trioxide; Arsenicals; Carrier Proteins; Cell Line; HIV-1; Humans; Infectious Anemia Virus, Equine; Leukemia Virus, Murine; Leupeptins; Mice; Oxides; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-mdm2; RNA Interference; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2010 |
NFκB inhibitors induce cell death in glioblastomas.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cisplatin; Curcumin; Doxorubicin; Drug Synergism; Glioblastoma; Humans; Leupeptins; Molecular Targeted Therapy; NF-kappa B; Nitriles; Oxides; Rats; Sesquiterpenes; Signal Transduction; Sulfones | 2011 |
Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein.
Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Leupeptins; Oxides; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; RNA, Messenger; Signal Transduction; Time Factors; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases | 2013 |
Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Autophagy; Cell Line, Tumor; Cell Survival; Drug Synergism; Enzyme Inhibitors; Humans; Leupeptins; Membrane Potential, Mitochondrial; Membrane Potentials; Membrane Proteins; Mitochondria; Oxides; Proto-Oncogene Proteins; U937 Cells; Up-Regulation; Valproic Acid; Vincristine | 2014 |
Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cysteine Proteinase Inhibitors; Drug Therapy, Combination; Female; Leupeptins; Lung Neoplasms; Mice; Mice, Nude; Oxides; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 1; Xenograft Model Antitumor Assays | 2016 |